Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

Alexandrov, 2013, Signatures of mutational processes in human cancer, Nature, 500, 415, 10.1038/nature12477 Babjuk, 2013, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013, Eur. Urol., 64, 639, 10.1016/j.eururo.2013.06.003 Birkenkamp-Demtroder, 2016, Genomic alterations in liquid biopsies from patients with bladder cancer, Eur. Urol., 10.1016/j.eururo.2016.01.007 Biton, 2014, Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes, Cell Rep., 9, 1235, 10.1016/j.celrep.2014.10.035 Blaveri, 2005, Bladder cancer outcome and subtype classification by gene expression, Clin. Cancer Res., 11, 4044, 10.1158/1078-0432.CCR-04-2409 Brockdorff, 2013, Noncoding RNA and polycomb recruitment, RNA, 19, 429, 10.1261/rna.037598.112 Cancer Genome Atlas Research Network, 2014, Comprehensive molecular characterization of urothelial bladder carcinoma, Nature, 507, 315, 10.1038/nature12965 Choi, 2014, Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer, Nat. Rev. Urol., 11, 400, 10.1038/nrurol.2014.129 Choi, 2014, Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy, Cancer Cell, 25, 152, 10.1016/j.ccr.2014.01.009 Cingolani, 2012, A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3, Fly (Austin), 6, 80, 10.4161/fly.19695 Damrauer, 2014, Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology, Proc. Natl. Acad. Sci. USA, 111, 3110, 10.1073/pnas.1318376111 de Bruin, 2014, Spatial and temporal diversity in genomic instability processes defines lung cancer evolution, Science, 346, 251, 10.1126/science.1253462 Dyrskjot, 2003, Identifying distinct classes of bladder carcinoma using microarrays, Nat. Genet., 33, 90, 10.1038/ng1061 Dyrskjot, 2004, Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification, Cancer Res., 64, 4040, 10.1158/0008-5472.CAN-03-3620 Dyrskjot, 2007, Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study, Clin. Cancer Res., 13, 3545, 10.1158/1078-0432.CCR-06-2940 Dyrskjot, 2012, Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR, Br. J. Cancer, 107, 1392, 10.1038/bjc.2012.412 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 Gallego Romero, 2014, RNA-seq: impact of RNA degradation on transcript quantification, BMC Biol., 12, 42, 10.1186/1741-7007-12-42 Gehring, 2015, SomaticSignatures: inferring mutational signatures from single-nucleotide variants, Bioinformatics, 31, 3673, 10.1093/bioinformatics/btv408 Gonzalez-Perez, 2013, IntOGen-mutations identifies cancer drivers across tumor types, Nat. Methods, 10, 1081, 10.1038/nmeth.2642 Han, 2015, The genomic landscape and clinical relevance of a-to-I RNA editing in human cancers, Cancer Cell, 28, 515, 10.1016/j.ccell.2015.08.013 Hong, 2008, Economic impact of tumor markers in bladder cancer surveillance, Urology, 71, 131, 10.1016/j.urology.2007.08.014 Jung, 2014, The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu, Ann. Diagn. Pathol., 18, 27, 10.1016/j.anndiagpath.2013.10.006 Kim, 2013, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol., 14, R36, 10.1186/gb-2013-14-4-r36 Kim, 2015, Invasive bladder cancer: genomic insights and therapeutic promise, Clin. Cancer Res., 21, 4514, 10.1158/1078-0432.CCR-14-1215 Lawson, 2015, Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells, Nature, 526, 131, 10.1038/nature15260 Maraver, 2015, NOTCH pathway inactivation promotes bladder cancer progression, J. Clin. Invest., 125, 824, 10.1172/JCI78185 McKenna, 2010, The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res., 20, 1297, 10.1101/gr.107524.110 Montes, 2015, The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence, Nat. Commun., 6, 6967, 10.1038/ncomms7967 Nie, 2015, Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer, Tumour Biol. Nordentoft, 2014, Mutational context and diverse clonal development in early and late bladder cancer, Cell Rep., 7, 1649, 10.1016/j.celrep.2014.04.038 Patschan, 2015, A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma, Eur. Urol., 68, 824, 10.1016/j.eururo.2015.02.021 Rampias, 2014, A new tumor suppressor role for the Notch pathway in bladder cancer, Nat. Med., 20, 1199, 10.1038/nm.3678 Rebouissou, 2014, EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype, Sci. Transl. Med., 6, 244ra291, 10.1126/scitranslmed.3008970 Roberts, 2013, An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers, Nat. Genet., 45, 970, 10.1038/ng.2702 Rubio-Perez, 2015, In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities, Cancer Cell, 27, 382, 10.1016/j.ccell.2015.02.007 Sanchez-Carbayo, 2006, Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays, J. Clin. Oncol., 24, 778, 10.1200/JCO.2005.03.2375 Shin, 2014, Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors, Cancer Cell, 26, 521, 10.1016/j.ccell.2014.09.001 Sieuwerts, 2014, Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers, Horm. Cancer, 5, 405, 10.1007/s12672-014-0196-8 Sjodahl, 2012, A molecular taxonomy for urothelial carcinoma, Clin. Cancer Res., 18, 3377, 10.1158/1078-0432.CCR-12-0077-T Spruck, 1994, Two molecular pathways to transitional cell carcinoma of the bladder, Cancer Res., 54, 784 Swanton, 2015, Apobec enzymes: mutagenic fuel for cancer evolution and heterogeneity, Cancer Discov., 5, 704, 10.1158/2159-8290.CD-15-0344 Tai, 2013, Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas, PLoS One, 8, e81167, 10.1371/journal.pone.0081167 Thorsen, 2008, Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis, Mol. Cell Proteomics, 7, 1214, 10.1074/mcp.M700590-MCP200 Trapnell, 2010, Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation, Nat. Biotechnol., 28, 511, 10.1038/nbt.1621 van der Horst, 2012, Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma, Mol. Cancer Res., 10, 995, 10.1158/1541-7786.MCR-12-0274 van Rhijn, 2003, Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome, J. Clin. Oncol., 21, 1912, 10.1200/JCO.2003.05.073 Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 Volkmer, 2012, Three differentiation states risk-stratify bladder cancer into distinct subtypes, Proc. Natl. Acad. Sci. USA, 109, 2078, 10.1073/pnas.1120605109 Waclaw, 2015, A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity, Nature, 525, 261, 10.1038/nature14971 West, 2014, The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites, Mol. Cell, 55, 791, 10.1016/j.molcel.2014.07.012 Wilkerson, 2010, ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking, Bioinformatics, 26, 1572, 10.1093/bioinformatics/btq170 Zhang, 2014, EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression, Sci. Rep., 4, 5416, 10.1038/srep05416